Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,690,230
+$7,718,652 QoQ
Shares Held
283,572
+64.2% QoQ
Ownership
0.204%
of shares outstanding
% of Portfolio
3.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$26,917,644
CallShares
408,400
PutValue
$36,283,455
PutShares
550,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in CYTK
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,917,644 | 408,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $36,283,455 | 550,500 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $18,690,230 | 283,572 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,483,786 | 290,900 | Call | Sole | 2026-02-18 | |
| 2025-12-31 | $10,971,578 | 172,672 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $6,095,064 | 110,900 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $12,238,163 | 222,674 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,713,650 | 233,464 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $4,956,000 | 150,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $6,027,776 | 149,982 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,055,153 | 149,982 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,761,440 | 52,300 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $8,983,761 | 170,147 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,218,564 | 170,147 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,011,000 | 100,000 | Put | Sole | 2024-05-17 | |
| 2024-03-31 | $10,176,256 | 145,147 | Shares | Sole | 2024-05-17 | |
| 2023-12-31 | $50,386,215 | 603,500 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $2,504,700 | 30,000 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $292,215 | 3,500 | Put | Sole | 2024-02-14 | |
| 2023-09-30 | $59,951 | 2,035 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $59,951 | 2,035 | Put | Sole | 2023-11-14 | |
| 2023-03-31 | $1,958,886 | 55,666 | Shares | Sole | 2023-05-15 | |
| 2021-06-30 | $2,392,512 | 120,895 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $2,954,020 | 127,000 | Shares | Sole | 2021-08-18 | |
| 2020-12-31 | $4,717,060 | 227,000 | Shares | Sole | 2021-02-12 | |
| 2020-12-31 | $3,117,000 | 150,000 | Call | Sole | 2021-02-12 | |
| 2020-09-30 | $6,928,000 | 320,000 | Put | Sole | 2020-11-16 | |
| 2020-09-30 | $25,365,140 | 1,171,600 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | $1,190,750 | 55,000 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $5,895,000 | 500,000 | Call | Sole | 2020-05-15 | |
| 2020-03-31 | $4,532,076 | 384,400 | Put | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||